| Comparaison de concurrents directs | |
|---|
| RELV | HLF | MTEX | NATR | Secteur |
|---|
| Cap. boursière : | 16,65M | 4,94Mds | 29,65M | 260,16M | 71,76Mds |
|---|
| Employés : | 214 | 6 200 | 310 | 995 | 450,00 |
|---|
| Croiss. Trim. du CA (yoy): | -0,05 | 0,17 | -0,06 | 0,04 | 0,27 |
|---|
| Chiffre d’affaires (ttm):
| 67,82M | 4,23Mds | 170,61M | 371,08M | 13,93Mds |
|---|
| Marge brute (ttm) : | 0,80 | 0,47 | 0,38 | 0,75 | 0,72 |
|---|
| EBITDA (ttm) : | 2,16M | 753,02M | 4,75M | 37,27M | 1,51Mds |
|---|
| Marge d’exploitation (ttm):
| 0,02 | 0,16 | 0,01 | 0,09 | 0,13 |
|---|
| Bénéfice net (ttm) : | 1,02M | 487,88M | 656,00k | 23,02M | N/D |
|---|
| BPA (ttm): | 0,08 | 4,28 | 0,25 | 1,43 | 0,61 |
|---|
| PER (ttm) : | 16,10 | 11,22 | 45,16 | 11,45 | 18,43 |
|---|
| PEG (attendu 5 ans) | N/D | 0,65 | N/D | N/D | 1,51 |
|---|
| P/S (ttm) : | 0,25 | 1,21 | 0,18 | 0,73 | 3,64 |
|---|
|
| HLF = Herbalife Ltd. | | MTEX = Mannatech, Incorporated | | NATR = Nature's Sunshine Products Inc. | | Secteur = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Société | Symbole | Cours | Variation | Cap. boursière | PER |
|---|
| Amgen Inc. | AMGN | 99,18 | -0,02 | 74,38Mds | 16,79 |
|---|
| Genentech, Inc. | "Privé" |
|---|
| Biogen Idec Inc. | BIIB | 203,80 | -0,03 | 48,38Mds | 32,34 |
|---|
| Genzyme Corporation | "Privé" |
|---|
| Merck Serono S.A. | "Privé" |
|---|
| Gilead Sciences Inc. | GILD | 50,60 | -0,03 | 77,18Mds | 28,33 |
|---|
| MedImmune, L.L.C. | "Privé" |
|---|
| Life Technologies Corporation | LIFE | 74,21 | -0,00 | 12,77Mds | 31,42 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39,30 | -0,01 | 33,48Mds | 19,62 |
|---|
| Sandoz International GmbH | "Privé" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Société | Symbole | Cours | Variation | Cap. boursière | PER |
|---|
| Actavis, Inc. | ACT | 123,71 | -0,02 | 15,80Mds | N/D |
|---|
| Ranbaxy Laboratories Limited | "Privé" |
|---|
| Mylan, Inc. | MYL | 31,27 | -0,02 | 11,92Mds | 20,89 |
|---|
| Pfizer Inc. | PFE | 29,10 | -0,01 | 206,41Mds | 13,93 |
|---|
| Johnson & Johnson | JNJ | 84,86 | -0,02 | 238,36Mds | 23,05 |
|---|
| GlaxoSmithKline plc | GSK | 51,48 | -0,02 | 124,68Mds | 18,82 |
|---|
| Sanofi | SNY | 53,40 | -0,02 | 141,34Mds | 26,32 |
|---|
| Novartis AG | NVS | 71,90 | -0,02 | 176,67Mds | 18,25 |
|---|
| Roche Holding AG | RHHBY | 61,90 | -0,01 | 210,08Mds | 20,72 |
|---|
| AstraZeneca PLC | AZN | 50,19 | -0,02 | 62,74Mds | 11,10 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Société | Symbole | Cours | Variation | Cap. boursière | PER |
|---|
| Abbott Laboratories | ABT | 36,21 | -0,03 | 56,45Mds | 11,04 |
|---|
| Bristol-Myers Squibb Company | BMY | 46,05 | -0,02 | 75,64Mds | 52,15 |
|---|
|
| Actualités des concurrents directs | |
|---|
Devise : USD. | |
|
0,55%